Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-12-01FDA Approved: TALTZ — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for TALTZ (ixekizumab) submitted by Eli Lilly and Company, resulting in an expanded label for additi…
-
FDA approval · 2017-10-25FDA Approved: CLOBETASOL PROPIONATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for clobetasol propionate from Macleods Pharmaceuticals Limited.
-
FDA approval · 2017-09-22FDA Approved: CLOBETASOL PROPIONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for clobetasol propionate as a generic topical corticosteroid.
-
FDA approval · 2017-07-13FDA Approved: TREMFYA — Original Application (Janssen Biotech, Inc.)
The FDA approved TREMFYA (guselkumab) from Janssen Biotech as the original application for the treatment of moderate to severe plaque psoria…
-
FDA approval · 2017-06-19FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for Taclonex (calcipotriene and betamethone dipropionate) from LEO Pharma Inc., under NDA 022185…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-04-21FDA Approved: RENFLEXIS — Original Application (Organon LLC)
The FDA approved RENFLEXIS (infliximab) from Organon LLC based on an original application, making it a biosimilar to Remicade. The approval …
-
FDA approval · 2017-04-03FDA Approved: TAZAROTENE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic tazarotene via an original ANDA submission.
-
FDA approval · 2017-03-20FDA Approved: CLOBETASOL PROPIONATE — Original Application (Northstar Rx LLC)
FDA approved the original application for a generic clobetasol propionate topical corticosteroid, manufactured by Northstar Rx LLC. The appr…
-
FDA approval · 2017-02-15FDA Approved: SILIQ — Original Application (Bausch Health US LLC)
FDA approved SILIQ (brodalumab) from Bausch Health US LLC in its Original Application for adults with moderate-to-severe plaque psoriasis, w…
-
FDA approval · 2017-01-11FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)
The FDA approved a supplemental application for OTREXUP (methotrexate) filed by Antares Pharma, Inc. This update expands the regulatory auth…
-
FDA approval · 2016-12-13FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.
-
FDA approval · 2016-09-23FDA Approved: USTEKINUMAB — Original Application (Janssen Biotech, Inc.)
FDA approved ustekinumab (brand name Stelara) in its original application for the treatment of moderate to severe plaque psoriasis in adults…
-
FDA approval · 2016-06-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) to Cordavis Limited, authorizing the continued manufacturing/supply of the p…
-
FDA approval · 2016-06-21FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental NDA for Taclonex (calcipotriene and betamethasone dipropionate) by LEO Pharma Inc.
-
FDA approval · 2016-06-20FDA Approved: ENSTILAR — Supplemental Application (LEO Pharma Inc.)
The FDA approved a supplemental application for ENSTILAR (calcipotriol and betamethasone dipropionate) submitted by LEO Pharma Inc.
-
FDA approval · 2016-05-12FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., authorizing changes to the approved produc…
-
FDA approval · 2016-04-25FDA Approved: FLUOCINOLONE ACETONIDE OIL — Original Application (Rising Pharma Holdings, Inc.)
FDA approves Rising Pharma Holdings' Fluocinonide Acetonide Oil as a generic topical corticosteroid for inflammatory and pruritic skin condi…
-
FDA approval · 2016-04-15FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. This action typically accomp…
-
FDA approval · 2016-04-05FDA Approved: INFLECTRA — Original Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved INFLECTRA (infliximab-dyyb) as a biosimilar to infliximab for multiple autoimmune diseases, expanding access to a biologic ther…
-
FDA approval · 2016-03-22FDA Approved: TALTZ — Original Application (Eli Lilly and Company)
The FDA approved the original Biologics License Application for TALTZ (ixekizumab) from Eli Lilly for the treatment of plaque psoriasis in a…
-
FDA approval · 2016-03-18FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for Taclonex (calcipotriene and betamethasone dipropionate) from LEO Pharma Inc. This action may inv…
-
FDA approval · 2016-02-05FDA Approved: SERNIVO — Original Application (Primus Pharmaceuticals, Inc.)
FDA approved SERNIVO (betamethasone dipropionate) from Primus Pharmaceuticals in an original NDA for the topical treatment of plaque psorias…
-
FDA approval · 2015-12-21FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for OTEZLA (apremilast) from Amgen that updated its labeling.
-
FDA approval · 2015-11-23FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) filed by Cordavis Limited, indicating regulatory action on a Humira supp…
-
FDA approval · 2015-10-29FDA Approved: TACLONEX — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for TACLONEX (calcipotriene and betamethone dipropionate) from LEO Pharma Inc.